HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Anna M Blom Selected Research

Proteinuria

1/2020Noncanonical immunomodulatory activity of complement regulator C4BP(β-) limits the development of lupus nephritis.
1/2019Measuring plasma C4D to monitor immune complexes in lupus nephritis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Anna M Blom Research Topics

Disease

26Inflammation (Inflammations)
05/2024 - 09/2005
23Neoplasms (Cancer)
04/2024 - 01/2005
18Rheumatoid Arthritis
01/2023 - 01/2007
16Infections
01/2023 - 05/2005
13Breast Neoplasms (Breast Cancer)
05/2023 - 01/2013
12Atypical Hemolytic Uremic Syndrome
12/2021 - 03/2007
8Arthritis (Polyarthritis)
01/2023 - 09/2006
8Systemic Lupus Erythematosus (Libman-Sacks Disease)
11/2016 - 02/2010
7Autoimmune Diseases (Autoimmune Disease)
01/2023 - 08/2011
7Macular Degeneration (Age-Related Maculopathy)
01/2021 - 04/2007
6Joint Diseases (Joint Disease)
01/2013 - 09/2005
5Type 2 Diabetes Mellitus (MODY)
01/2022 - 11/2012
5Glomerulonephritis
01/2019 - 08/2011
3Fibrosis (Cirrhosis)
04/2024 - 01/2022
3Adenocarcinoma
04/2024 - 01/2022
3Lung Neoplasms (Lung Cancer)
02/2024 - 01/2008
3Lyme Disease (Disease, Lyme)
01/2022 - 03/2010
3Gonorrhea
01/2021 - 11/2005
3Hemolysis
01/2021 - 08/2009
3B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2020 - 12/2013
3Lymphoma (Lymphomas)
01/2020 - 11/2007
3Lupus Nephritis
01/2020 - 12/2017
3Alzheimer Disease (Alzheimer's Disease)
01/2019 - 08/2008
3Rheumatic Diseases (Rheumatism)
09/2017 - 08/2012
3Osteoarthritis
10/2016 - 01/2012
3Thrombosis (Thrombus)
10/2015 - 08/2012
3Scabies (Sarcoptic Mange)
05/2014 - 06/2009
3Kaposi Sarcoma (Kaposi's Sarcoma)
02/2011 - 01/2007
2Lymphatic Metastasis
04/2024 - 11/2021
2Neuroinflammatory Diseases
04/2024 - 01/2019
2Experimental Arthritis
01/2023 - 10/2010
2Hyperglycemia
01/2022 - 01/2017
2Proteinuria
01/2020 - 01/2019
2Pancreatitis
01/2020 - 09/2005
2Kidney Diseases (Kidney Disease)
01/2019 - 01/2011
2Bacterial Infections (Bacterial Infection)
12/2017 - 07/2015
2Systemic Scleroderma (Systemic Sclerosis)
11/2016 - 01/2013
2Necrosis
10/2016 - 06/2004
2Wounds and Injuries (Trauma)
10/2016 - 04/2012
2Nephritis
09/2014 - 01/2011
2Acquired Immunodeficiency Syndrome (AIDS)
03/2013 - 04/2006
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2009 - 01/2008
1Ovarian Neoplasms (Ovarian Cancer)
04/2024
1Glioma (Gliomas)
04/2024
1Brain Neoplasms (Brain Tumor)
04/2024
1Schizophrenia (Dementia Praecox)
03/2024

Drug/Important Bio-Agent (IBA)

81Complement System Proteins (Complement)IBA
05/2024 - 03/2003
25Complement Inactivating AgentsIBA
04/2024 - 01/2007
21Proteins (Proteins, Gene)FDA Link
01/2023 - 01/2005
13AntibodiesIBA
01/2023 - 10/2007
13Complement C4b-Binding ProteinIBA
11/2016 - 11/2005
12Cartilage Oligomeric Matrix ProteinIBA
04/2024 - 12/2010
11Complement Factor H (Factor H)IBA
01/2020 - 09/2005
9AutoantibodiesIBA
01/2023 - 02/2010
8Fibrinogen (Factor I)FDA Link
11/2020 - 03/2007
6VaccinesIBA
01/2023 - 05/2005
6DNA (Deoxyribonucleic Acid)IBA
01/2022 - 04/2007
6Immunoglobulin G (IgG)IBA
01/2020 - 10/2007
5CollagenIBA
04/2024 - 10/2010
5Complement Factor I (C3b Inactivator)IBA
02/2024 - 01/2008
5Biomarkers (Surrogate Marker)IBA
11/2021 - 12/2013
4Messenger RNA (mRNA)IBA
12/2022 - 11/2009
4LigandsIBA
01/2022 - 03/2003
4Monoclonal AntibodiesIBA
01/2020 - 10/2013
3Insulin (Novolin)FDA Link
01/2022 - 05/2014
3Protein Isoforms (Isoforms)IBA
01/2022 - 07/2009
3CytokinesIBA
01/2020 - 09/2005
3Antigen-Antibody Complex (Immune Complex)IBA
01/2019 - 06/2013
3AsparagineIBA
01/2018 - 10/2007
3Polysaccharides (Glycans)IBA
01/2018 - 10/2007
3Peptide Hydrolases (Proteases)FDA Link
10/2016 - 06/2007
3Complement Membrane Attack Complex (Membrane Attack Complex)IBA
10/2016 - 08/2009
3AnticoagulantsIBA
01/2016 - 08/2012
3LectinsIBA
05/2014 - 02/2011
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
11/2023 - 11/2016
2InterleukinsIBA
11/2023 - 10/2016
2ErbB Receptors (EGF Receptor)IBA
05/2023 - 08/2021
2AntigensIBA
01/2020 - 02/2011
2Rituximab (Mabthera)FDA Link
01/2020 - 12/2013
2Complement C3 (C3 Complement)IBA
01/2020 - 01/2019
2ofatumumabFDA Link
01/2020 - 12/2013
2anti-dsDNA autoantibodyIBA
01/2020 - 12/2017
2VitronectinIBA
01/2018 - 08/2009
2Acetylglucosaminidase (NAGase)IBA
01/2018 - 06/2013
2Aggrecans (Aggrecan)IBA
10/2016 - 01/2013
2EpitopesIBA
04/2016 - 01/2005
2Protein SIBA
01/2016 - 06/2006
2Complement 3d Receptors (Complement Receptor 2)IBA
09/2014 - 03/2003
2Serine Proteases (Serine Protease)IBA
05/2014 - 06/2009
2serglycinIBA
01/2013 - 02/2011
2Annexin A2 (Annexin II)IBA
09/2012 - 02/2010
2FibromodulinIBA
04/2007 - 09/2005
1CateninsIBA
04/2024
1Proto-Oncogene Proteins c-sis (Platelet Derived Growth Factor B)IBA
04/2024
1Thrombopoietin ReceptorsIBA
12/2023

Therapy/Procedure

4Immunotherapy
01/2023 - 01/2020
3Therapeutics
12/2023 - 11/2016
3Drug Therapy (Chemotherapy)
08/2021 - 01/2005
2Immunomodulation
11/2023 - 01/2020
1Radiotherapy
04/2024